A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis

  • Ilia Voskoboinik
    From the Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Marie-Claude Thia
    From the Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Joseph A. Trapani
    From the Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

説明

<jats:title>Abstract</jats:title><jats:p>Up to 60% of cases of the autosomal recessive immunodeficiency hemophagocytic lymphohistiocytosis (HLH) are associated with mutations in the perforin (PRF1) gene. In this study, we expressed wild-type and mutated perforin in rat basophil leukemia cells to study the effect on lytic function of the substitutions A91V and N252S (commonly considered to be neutral polymorphisms) and 22 perforin missense substitutions first identified in HLH patients. Surprisingly, we found that A91V perforin was expressed at reduced levels compared with wild-type perforin, resulting in partial loss of lytic capacity. In contrast, expression and function of N252S-substituted perforin were normal. Most HLH-associated mutations resulted in protein degradation (probably due to misfolding) and complete loss of perforin activity, the exception being R232H, which retained approximately 30% wild-type activity. Several other mutated proteins (H222Q, C73R, F157V, and D313V) had no detectable lytic activity but were expressed at normal levels, suggesting that their functional defect might map downstream at the level of the target cell membrane. One further perforin substitution identified in an HLH patient (V183G) was normally expressed and displayed normal lysis. This report represents the first systematic functional analysis of HLH-associated missense mutations and the 2 most common perforin polymorphisms. (Blood. 2005;105:4700-4706)</jats:p>

収録刊行物

  • Blood

    Blood 105 (12), 4700-4706, 2005-06-15

    American Society of Hematology

被引用文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ